Biomarin Pharmaceutical Inc (BMRN)

CIK 1048477 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Biomarin Pharmaceutical Inc.

Recent SEC filings

FiledFormAccession number
Nov 4, 2026SCHEDULE 13G/A0002012383-26-003968
Nov 3, 202610-Q0001048477-26-000023
Nov 2, 20268-K0001048477-26-000021
Oct 6, 20268-K0001048477-26-000019
Oct 1, 202640001628280-26-064272
Sep 30, 20268-K0001628280-26-063981
Sep 15, 20268-K0001628280-26-061973
Sep 14, 202630001628280-26-061934
Sep 14, 20268-K0001628280-26-061717
Sep 14, 202640001628280-26-061940
Sep 3, 202640001628280-26-060572
Sep 2, 20261440001959173-26-006644
Sep 1, 20268-K0001193125-26-377696
Aug 31, 20268-K0001193125-26-375275
Aug 18, 20268-K0001193125-26-354780
Aug 6, 20268-K0001048477-26-000015
Aug 6, 2026S-80001193125-26-338468
Aug 6, 202610-Q0001048477-26-000016
Jul 13, 20268-K/A0001048477-26-000011
Jun 4, 202640001628280-26-040911
Jun 4, 202640001628280-26-040903
Jun 4, 202640001628280-26-040916
Jun 4, 202640001628280-26-040909
Jun 4, 20268-K0001628280-26-040812
Jun 4, 202640001628280-26-040920